Filtered By:
Management: Food and Drug Administration (FDA)
Countries: Canada Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 27 results found since Jan 2013.

FDA Clears Second Bivalent COVID-19 Booster for People 65 and Older
WASHINGTON — U.S. regulators on Tuesday cleared another COVID-19 booster dose for older adults and people with weak immune systems so they can shore up protection this spring — while taking steps to make coronavirus vaccinations simpler for everyone else. The Food and Drug Administration said anyone 65 or older can opt to roll up their sleeves again as long as it’s been at least four months since their first dose of the so-called bivalent vaccine that targets Omicron strains. And most people who are immune-compromised can choose another bivalent booster shot at least two months later, with additional dose...
Source: TIME: Health - April 18, 2023 Category: Consumer Health News Authors: Lauran Neergaard/AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

News at a glance: New U.S. coronavirus research, lab gear ’s carbon cost, and a repurposed accelerator
MATERIALS SCIENCE Storied accelerator to test chips The world’s first superconducting cyclotron will receive a new lease on life testing next-generation microchips, Michigan State University’s Facility for Rare Isotope Beams (FRIB) announced last week. From 1982 to 2020, the K-500 cyclotron produced beams of atomic nuclei ranging from hydrogen to uranium for experiments in nuclear physics, relying on superconducting magnets to confine the particles. Last year, the cyclotron was replaced by FRIB’s new, more powerful, $730 million linear accelerator. Typically, old particle accelerators are demolished or...
Source: Science of Aging Knowledge Environment - April 13, 2023 Category: Geriatrics Source Type: research

Should You Get Another Covid Booster?
Britain and Canada have authorized another round of booster shots for older and immunocompromised citizens. So far, U.S. officials haven ’t followed suit.
Source: NYT Health - March 24, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Coronavirus (2019-nCoV) Vaccination and Immunization Elderly Immune System Food and Drug Administration Source Type: news

Second Phase of the NIH Preprint Pilot Launched
Today, we are pleased to announce the launch of the second phase of the NIH Preprint Pilot with the addition of more than 700 new preprint records to PubMed Central (PMC) and PubMed. This second phase expands the scope of the Pilot to include preprints resulting from all NIH-funded research. Eligible preprints are those acknowledging direct support of an NIH award or authored by NIH staff and posted to bioRxiv, medRxiv, arXiv, or Research Square, on or after January 1, 2023. NLM will automatically include the full text of the preprint (as license terms allow) and associated citation information in PMC and PubMed, respectiv...
Source: PubMed Central News - January 30, 2023 Category: Databases & Libraries Source Type: news

What ’s next for COVID-19 vaccines? Scientists and regulators chart a course amid uncertainty
Just over 2 years ago, the first COVID-19 vaccines arrived—and a roller coaster ride of hope and science began. It soon became clear that although the vaccines protected against severe disease, their ability to fend off infection was limited and faded fast. Meanwhile, SARS-CoV-2 began to evolve rapidly to elude immunity. By now, many people have had four or five vaccine doses, including an updated booster tailored to Omicron strains that was introduced last fall. Now, regulators and scientists are debating the near-term future. How often will we need booster doses and who should receive them? Should vaccines continu...
Source: Science of Aging Knowledge Environment - January 25, 2023 Category: Geriatrics Source Type: research

Next Phase of NIH Preprint Pilot Launching Soon
Last month, the National Library of Medicine (NLM)announced plans to extend its NIH Preprint Pilot in PubMed Central (PMC) and PubMed beyond COVID-19 to encompass all preprints reporting on NIH-funded research. The second phase of the pilot, launching later this month, will include preprints supported by an NIH award, contract, or intramural program and posted to aneligible preprint server on or after January 1, 2023.In preparation for the launch of this second phase, we have updated PMC and PubMed site features to help users of these databases incorporate the increased volume of preprints into their discovery workflows. S...
Source: PubMed Central News - January 10, 2023 Category: Databases & Libraries Source Type: news

News at a glance: Omicron vaccine, colonial-era exploitation, and mapping health equity
IN FOCUS Scientists rallied outside Canada’s Parliament on 11 August, carrying a 70-meter-long letter with more than 7000 signatures. The letter to lawmakers calls for increases in the stipends paid by graduate student scholarships and postdoctoral fellowships awarded by the Natural Sciences and Engineering Research Council of Canada. “We can’t do science if we can’t pay rent,” one rallygoer’s sign read. COVID-19 U.K. OKs anti-Omicron vaccine The United Kingdom this week became the first country to approve an updated COVID-19 booster directed at two different strains of the coronavi...
Source: ScienceNOW - August 18, 2022 Category: Science Source Type: news

What to Know About the Latest Advances in Managing Severe Asthma
Graphs and charts don’t always tell the whole story. Numbers can be deceiving. But anyone who looks at U.S. trends in asthma mortality can see, without squinting, that things are moving in the right direction. A 2019 analysis in the American Journal of Respiratory and Critical Care Medicine found that from 1999 to 2015, asthma mortality fell by 43%. “The decrease in asthma-related mortality was consistent in both sexes and in all race groups, with the largest decrease in patients older than 65 years,” the authors concluded. Figures from the U.S. Centers for Disease Control and Prevention indicate that the...
Source: TIME: Health - June 23, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news

FDA authorizes COVID-19 vaccines for kids under 5 in the U.S.
On Friday, the U.S. Food and Drug Administration authorized coronavirus vaccines for children under five years of age. Canadian children under five cannot yet be vaccinated against COVID-19, as Health Canada is still reviewing Moderna's vaccine submission.
Source: CBC | Health - June 17, 2022 Category: Consumer Health News Tags: News/Health Source Type: news

A Fourth COVID-19 Vaccine, From Novovax, Passed a Key Stage in the Authorization Process
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. It’s made with more conventional technology than today’s dominant Pfizer and Moderna shots and the lesser-used Johnson & Johnson option. Novavax shots are already available in Australia, Canada, parts of Europe and multiple other countries, either for initial va...
Source: TIME: Health - June 8, 2022 Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

FDA Advisers Back a New COVID-19 Vaccine, Made By Novavax
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that’s made with a more conventional technology than today’s U.S. options. Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company. FDA’s vaccine chief Dr. Peter Marks said another choice in the U....
Source: TIME: Health - June 7, 2022 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized COVID-19 wire Source Type: news

U.S. FDA grants priority review to Roche ’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
If approved,Actemra/RoActemra would be the first U.S. FDA-approvedimmunomodulator for the treatment of COVID-19 inhospitalised patientsSince the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra/RoActemra worldwide1Actemra/RoActemra is approved for the treatment of COVID-19 in many territories including the European UnionRoche has established a comprehensive access approach to improve availability ofActemra/RoActemra around the worldBasel, 04 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has acce...
Source: Roche Investor Update - April 4, 2022 Category: Pharmaceuticals Source Type: news

Pfizer Asks FDA to OK COVID-19 Booster Shots for All Adults
Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings. Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine since September. But the Food and Drug Administration (FDA) has said it would move quickly to expand boosters to younger ages if warranted. Pfizer is submitting early results of a booster study in 10,000 people to make its case that it’s time to further expand the booster ca...
Source: TIME: Health - November 10, 2021 Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

FDA Authorizes Booster Shot of COVID-19 Vaccine for People With Weakened Immune Systems
WASHINGTON (AP) — U.S. regulators say transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect them as the delta variant continues to surge. The late-night announcement Thursday by the Food and Drug Administration applies to several million Americans who are especially vulnerable because of organ transplants, certain cancers or other disorders. Several other countries, including France and Israel, have similar recommendations. It’s harder for vaccines to rev up an immune system suppressed by certain medications and ...
Source: TIME: Health - August 13, 2021 Category: Consumer Health News Authors: AP / Lauran Neergaard and Matthew Perrone Tags: Uncategorized COVID-19 Source Type: news